How long does ibogaine treatment take from start to finish?

A typical medically supervised ibogaine program runs five to ten days on site: one to two days of intake and cardiac screening, one to two days of stabilization, the dosing day itself, several days of monitored noribogaine tail, and structured integration before discharge. Some programs extend this further for people managing a supervised opioid or benzodiazepine taper beforehand.

What happens on the actual dosing day?

After a physician confirms screening results are clear, ibogaine is administered — often as a test dose followed by the full dose — while the client remains on continuous cardiac telemetry. Effects typically begin within 30 to 90 minutes, an acute visionary phase runs several hours, and a longer introspective phase can continue for 12 to 24 hours, all under direct observation.

Why is cardiac monitoring emphasized so heavily during treatment?

Ibogaine and its active metabolite noribogaine block the hERG cardiac potassium channel, which can prolong the QT interval and create a risk of the arrhythmia torsades de pointes. This is the field's principal documented safety concern, which is why pre-treatment ECG screening and continuous telemetry during and after dosing are treated as non-negotiable rather than optional extras.

What is the noribogaine tail and why does it matter?

Ibogaine is metabolized into noribogaine, which has a much longer half-life and continues to affect cardiac conduction and subjective state for days after the acute experience ends. Responsible programs keep clients on site and on monitoring through this tail period rather than discharging someone as soon as the visionary phase subsides.

How Ibogaine Treatment Works: Day by Day

In brief: Understanding how ibogaine treatment works means understanding a sequence, not a single event. A responsible program moves a client through cardiac screening, physical stabilization, a closely monitored dosing day, a multi-day noribogaine tail, and structured integration before discharge. This walks through that sequence day by day. Educational only; not medical advice, and not a promise of any outcome.

How ibogaine treatment works — intake and cardiac screening before ibogaine dosing

Day 1–2: Intake and Cardiac Screening

Every credible answer to how ibogaine treatment works starts before ibogaine is ever administered. On arrival, intake typically includes a full medical and psychiatric history, a review of every medication and supplement the client is taking, and a physical exam. The centerpiece of this stage is cardiac: a 12-lead ECG with a measured QTc interval, because ibogaine and its metabolite noribogaine are known to prolong cardiac repolarization and can increase the risk of the arrhythmia torsades de pointes.

A comprehensive metabolic panel checks electrolytes — particularly potassium and magnesium — since abnormalities in either can compound cardiac risk during dosing. Many programs also order an echocardiogram and a cardiology consultation for anyone with a relevant history. This screening stage is described in more depth in our guide to ibogaine cardiac safety screening, and it is the single stage that should never be shortened, regardless of how a program prices its ibogaine treatment package.

Anyone with a prolonged baseline QTc, uncorrected electrolyte abnormality, structural heart disease, a history of arrhythmia, or certain drug interactions (including many antidepressants, antipsychotics, and some antibiotics) is generally excluded from dosing until the issue is resolved or, in some cases, permanently. A program that skips this step, or treats it as a formality, is not practicing medicine — it is taking a gamble with someone else's cardiovascular system.

Day 2–3: Physical and Medication Stabilization

Once screening clears a client for dosing, most programs schedule one or more stabilization days before ibogaine is administered. This stage exists because ibogaine dosing is not something to layer directly on top of active withdrawal, dehydration, or an unresolved medication interaction.

For clients coming off opioids, this often means a supervised taper or a defined window of abstinence timed so that ibogaine is not introduced during acute, unmanaged withdrawal. For clients on medications with known QT-prolonging or CYP2D6-interacting properties, this stage is where a physician decides whether and how those medications need to be adjusted beforehand — never abruptly stopped without medical guidance. Hydration, electrolyte repletion, sleep, and a final physician sign-off typically close out this phase. Our overview of ibogaine's role in addiction treatment more broadly is on the ibogaine for addiction page.

This is also the point where nutritional and supportive therapies are typically introduced — light meals, IV hydration where indicated, and rest — to bring the client into dosing day in the most stable physical condition realistically achievable.

How ibogaine treatment works — dosing day under continuous cardiac telemetry

Dosing Day, Hour by Hour

Dosing day is the part of the process most people picture when they ask how ibogaine treatment works, and it is the most heavily monitored day of the entire program. A representative timeline looks roughly like this, though exact timing varies by protocol and individual response:

Hour 0: A final physician check — vitals, hydration status, and a last confirmation of screening results — precedes administration. Continuous cardiac telemetry is placed and running before anything is given.
Hour 0–1: Many protocols begin with a smaller test dose, observing for any unexpected sensitivity before proceeding to the full dose.
Hour 1–2: Onset of effects, often reported as beginning 30 to 90 minutes after dosing — mild ataxia, tremor, and the start of a visionary, dream-like state.
Hour 2–6: The acute visionary phase. This is typically the most intense window, often involving vivid, panoramic, autobiographical imagery. The client is kept horizontal, supervised continuously, and monitored on telemetry throughout.
Hour 6–12: The visionary phase gradually gives way to a longer introspective, more reflective state, with reduced but still present perceptual effects.
Hour 12–24: A "gray day" or low-energy period is common, marked by fatigue, ataxia, and sometimes nausea, as noribogaine remains active in the system. Monitoring continues.

Throughout dosing day, medical staff are watching specifically for signs of QT prolongation, bradycardia, or ataxia severe enough to create a fall risk, and are equipped to intervene immediately if any of those appear. This is the phase where the difference between a fully staffed clinical program and an unsupervised one is starkest.

How ibogaine treatment works — the noribogaine tail and continued monitoring after dosing day

Day 4–6: The Noribogaine Tail

Ibogaine's acute effects end within roughly a day, but its active metabolite, noribogaine, has a much longer half-life and continues to circulate and affect cardiac conduction for days afterward. This is the "tail" of treatment, and it is a stage that gets skipped by less careful programs precisely because the client often looks and feels fine by this point.

A responsible program keeps the client on site and on periodic cardiac monitoring through this window, watches for delayed rebound symptoms, and does not discharge someone the same day the visionary effects wear off. Ongoing fatigue, mild ataxia, sleep disruption, and emotional intensity are common during the tail and are generally expected rather than alarming — but they should be observed by staff who know the difference between an expected recovery curve and an emerging problem. The documented risk profile during this period is covered in detail in our ibogaine safety and side effects guide.

Nutritional support, hydration, gentle movement, and sleep are the primary tools during the tail — the clinical work here is largely about patience and observation rather than intervention, unless monitoring reveals something that needs it.

Day 6–8: Integration

Integration is the stage most often shortchanged by programs that treat ibogaine purely as a chemical detox tool. The subjective experience during dosing is frequently described as intense, autobiographical, and emotionally significant, and without structured time to process it, much of the clinical value can be lost.

Integration days typically include one-on-one sessions to talk through what came up during the dosing experience, connect it to the person's history and current circumstances, and begin translating insight into a concrete plan. Complementary supportive therapies — bodywork, movement, and structured rest — are common during this phase, alongside continued attention to sleep and nutrition as the body finishes clearing noribogaine.

This is also when a realistic plan for what is often called a psychological "reset" period gets built: many people describe a temporary window of reduced cravings after ibogaine, and integration is where a program should be helping the client build the structures — outpatient support, sober living, therapy, family involvement — that need to be in place before that window closes.

How ibogaine treatment works — structured aftercare planning after ibogaine integration

Discharge and Aftercare

The final stage of how ibogaine treatment works is the one that happens after the client leaves the clinic, and it is the stage most correlated with whether the experience translates into durable change. Discharge planning should be concrete: a named outpatient provider or therapist, a specific plan for any medications that still need tapering, sober-living or family-support arrangements if relevant, and a follow-up check-in scheduled before the client walks out the door.

Programs vary enormously in how seriously they take this stage. Some treat it as an afterthought bundled into a brochure; others build it into the program itself with scheduled follow-up calls over the following weeks or months. When evaluating a program, this is one of the clearest signals of overall quality, alongside the criteria covered in our guide to choosing the best ibogaine treatment center.

No single ibogaine session is a guaranteed or permanent solution to substance use disorder, and any program suggesting otherwise should be treated with skepticism. What the day-by-day structure above is designed to do is give the body and mind a monitored, supported path through a physiologically significant experience — not to promise an outcome it cannot control.

Individual Variation: Why No Two Timelines Look Identical

The stages above describe a representative structure, but the actual hours a given person spends in each phase vary considerably. Body weight, prior substance use history, metabolic factors affecting how quickly ibogaine and noribogaine are cleared, and the dose protocol a physician selects all influence how long the acute visionary phase lasts and how pronounced the subsequent "gray day" fatigue becomes. Someone tapering off a long-term opioid regimen may present a different physiological picture on dosing day than someone whose primary goal is the psychological work described in the integration stage, and a responsible physician adjusts monitoring intensity accordingly rather than applying a single fixed template to every client.

This variability is also why a program's screening data from intake continues to matter well past Day 1. Baseline QTc, kidney and liver function, and body composition all factor into how a physician reads the telemetry on dosing day itself — a heart rate or QT reading that would be unremarkable for one client can be a meaningful flag for another. Programs that re-check vitals at each stage, rather than relying solely on the intake screening, are applying that individual context rather than treating the timeline as a fixed script.

None of this means the sequence of stages changes — screening, stabilization, dosing, tail, and integration remain the same backbone regardless of the individual. What changes is pacing: some clients need an extra stabilization day before screening clears them for dosing, and some need a longer tail before discharge is appropriate. A program that cannot flex its own schedule when a client's presentation calls for it is optimizing for a fixed calendar rather than for the person in front of it.

What This Timeline Depends On

Every stage described above depends on the same underlying condition: a program staffed and equipped to actually deliver it. A physician who reviews screening results personally. Continuous telemetry equipment that is actually in the room, not in a closet. Pharmaceutical-grade ibogaine with known, tested purity rather than an unregulated botanical extract of unknown potency. Staff awake and present through the entire dosing day and tail, not checking in periodically.

None of that is visible in a brochure. It is visible in the specific answers a program gives when you ask, in advance, exactly what happens hour by hour — which is precisely why this timeline is worth walking a prospective program through, question by question, before committing.

For a deeper look at what ibogaine is and how it is thought to act on the brain, see what ibogaine is. For the full checklist of safety infrastructure to verify before choosing a program, see our companion guide on how to choose an ibogaine treatment center, or explore our own ibogaine treatment program.

Editorial note: This article is educational and does not constitute medical advice, diagnosis, or a treatment recommendation. Ibogaine carries documented cardiac risk, including case reports of fatal arrhythmia, and must only be administered under qualified medical supervision with cardiac monitoring. It is not legal or approved as a medication in the United States. Anyone considering it should consult a qualified physician about their own medical history first.